IDH Inhibitors for AML

preview_player
Показать описание
Practical implications for using IDH inhibitors enasidenib and ivosidenib in patients with IDH1/2 mutations.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
IDH Inhibitors for 0:08:50

IDH Inhibitors for AML

A success story: 0:02:13

A success story: IDH inhibitors for AML

IDH inhibitors for 0:01:32

IDH inhibitors for AML and MDS

Case 3: IDH 0:05:29

Case 3: IDH Inhibitors for the Treatment of AML

Differentiation Syndrome and 0:09:08

Differentiation Syndrome and IDH Inhibitors in AML

IDH inhibition in 0:02:50

IDH inhibition in AML therapy

IDH1/2 Inhibitors in 0:06:35

IDH1/2 Inhibitors in AML

Dr. McCloskey Discusses 0:02:15

Dr. McCloskey Discusses IDH Inhibitors in AML

The promising role 0:01:53

The promising role of IDH inhibitors in AML

Updates on IDH 0:03:14

Updates on IDH inhibition in AML

IDH inhibitors in 0:00:59

IDH inhibitors in AML

IDH Mutations in 0:06:14

IDH Mutations in AML

Venetoclax-IDH inhibitor combination 0:03:08

Venetoclax-IDH inhibitor combination therapy for AML

IDH inhibitors and 0:00:54

IDH inhibitors and the evolving AML treatment paradigm

IDH1/2 inhibitors for 0:06:41

IDH1/2 inhibitors for AML

IDH inhibitors 0:01:59

IDH inhibitors

IDH inhibitors for 0:01:25

IDH inhibitors for AML: highlights from ASH 2018

IDH Inhibition in 0:01:33

IDH Inhibition in Acute Myeloid Leukemia –Emergence of a New Therapeutic Era

Targeting IDH mutations 0:02:57

Targeting IDH mutations for the treatment of AML

IDH1/2 Inhibitors for 0:05:47

IDH1/2 Inhibitors for AML

The prognostic impact 0:02:53

The prognostic impact of IDH mutations and the role of IDH inhibitors in MDS

The impact of 0:02:08

The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigatio...

IDH inhibitors in 0:42:38

IDH inhibitors in relapsed/refractory AML

IDH Inhibitors and 0:04:06

IDH Inhibitors and MDS